news

July 3, 2019

Genomenon Report Reveals Gene Fusion Data a Critical Factor in Cancer Diagnostics and Drug Development

Genomenon has released a research report detailing clinically significant fusion genes reported through April 2019. Fusion genes have long been known to play an... Read More
July 12, 2019

Precision Medicine changing how value is created and delivered in biopharmaceutical and diagnostics industries

Newsweek has released the results of a new report on precision medicine from their Vantage Thought Leadership division. The report, entitled Precision Medicine: Creating... Read More
July 12, 2019

GNS Healthcare Raises $23 Million Led by Cigna Ventures

GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate... Read More
July 12, 2019

Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment

Agilent Technologies Inc. (NYSE: A) has announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax... Read More
July 12, 2019

Be The Match BioTherapies® and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies

–Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Tmunity Therapeutics, Inc., a private clinical-stage... Read More
July 12, 2019

AmerisourceBergen Announces Long-Term Strategic Relationship with OneOncology

VALLEY FORGE, Pa.–(BUSINESS WIRE)–AmerisourceBergen, a global healthcare solutions leader, today announced that it has entered a long-term strategic relationship with OneOncology, the national partnership... Read More
April 12, 2019

Tumor Mutation Burden Study Shows Viability of In-House Testing

As laboratories increasingly look to bring advanced molecular testing in-house, the results of a new retrospective clinical research study show that tumor mutation burden... Read More
April 12, 2019

Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360

Guardant Health, Inc. (Nasdaq: GH), announced that its market leading liquid biopsy, Guardant360®, will be a covered benefit for the members of the health... Read More
April 12, 2019

SomaLogic announces new collaboration with Janssen Research & Development

SomaLogic, Inc. has announced that it has entered into a collaborative agreement with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies... Read More
April 12, 2019

FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia

The FH Foundation recently announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal... Read More
April 12, 2019

SOPHiA GENETICS Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection

SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight... Read More
April 3, 2019

PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive Health Management

Today, in collaboration with Helix, PerkinElmer, Inc., a global leader committed to innovating for a healthier world, launched GenePrism: Actionable Insights, a new genetic... Read More
April 3, 2019

Pat Basu, MD, MBA, named President and Chief Executive Officer of Cancer Treatment Centers of America

BOCA RATON, Fla., April 3, 2019 /PRNewswire/ — Pat A. Basu, MD, MBA, an accomplished health care executive and entrepreneur, has been appointed President... Read More
April 3, 2019

Roche launches NAVIFY Mutation Profiler and NAVIFY Therapy Matcher to support comprehensive genomic profiling in cancer

• CE-IVD marked software as a medical device that aids clinicians to more easily interpret NGS oncology tests • Classifies detected variants in accordance... Read More
April 2, 2019

Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing

WALTHAM, Mass. and CAMBRIDGE, Mass., March 24, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Brammer... Read More
MORE NEWS